Can Dosimetry Affect Overall Survival in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer Treated with Stereotactic Ablative Radiotherapy (SABR)? An Analysis of 1300 Patients

SABR is an established treatment option for early stage medically inoperable peripheral lung cancer. Recent studies have shown that tight conformity of radiotherapy plans i.e., reducing the radiation dose outside the target volume might worsen loco-regional control and can predict more distant metastases. The aim of the study is to report overall survival and dosimetry of early stage peripheral lung cancer patients treated with SABR and to try...